• Mashup Score: 0
    Systemic Therapy for Tumor Control in Well-Differentiated Metastatic Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline Q and A - 7 month(s) ago

    ASCO recently published new guidance on systemic therapy for tumor control in well-differentiated metastatic gastrointestinal and pancreatic neuroendocrine tumors in the Journal of Clinical Oncology. A companion Q and A article in the JCO-OP addresses some of the questions that clinicians may face as they implement these recommendations into clinical practice, including the role of somatostatin receptors and observation, definition of terms used within the guideline, considerations related to therapy options for G3 NETs, and future direction in research and treatment. ASCO also plans to address recommendations on the topic of symptom control of GEP-NETs in a forthcoming guideline

    Source: ascopubs.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JOP_ASCO
      JOP_ASCO

      ❓ #JCOOP Q&A for @ASCO's new guideline for systemic therapy for tumor control in well-differentiated metastatic gastrointestinal and pancreatic #neuroendocrine tumors. ➡️ https://t.co/upC2tLmwQ6 #NET #pancsm @JaydiDelRivero

  • Mashup Score: 1
    Clinical Trials - 10 month(s) ago

    UNDERSTANDING CLINICAL TRIALSFinding and learning more about relevant neuroendocrine cancer clinical trials may feel overwhelming. While comprehensive databases are available to search for trials, it may be difficult to understand whether a trial is right for you.  ​ Our goal is to offer a resource with key, open clinical trials for those with neuroendocrine cancer (aka, neuroendocrine…

    Source: LACNETS
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AmanChauhanMD
      AmanChauhanMD

      Nicely done @LACNETS It was a pleasure to collaborate. One stop shop for important #NET clinical trials. https://t.co/aIEnbaPx2f https://t.co/BeKAapcPlR

  • Mashup Score: 1
    Detectnet Webinar - 10 month(s) ago

    INDICATIONS AND USAGEDetectnet is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.IMPORTANT RISK INFORMATIONWARNINGS AND PRECAUTIONSRadiation Risk: Diagnostic radiopharmaceuticals, including Detectnet, contribute to a patient’s overall long-term cumulative radiation exposure. Long-term…

    Source: cu64detect.net
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AmanChauhanMD
      AmanChauhanMD

      Join us next Monday for a webinar on SSTR PET imaging. Explore the pivotal role of SSTR PET in #NET management with Dr. El Khouli and me. + live Q&A. Free registration! Don't miss out. Reserve your spot now! @NANETS1 @SylvesterCancer #Theranostics ➡️ https://t.co/hRrUkCDekO https://t.co/KkAusmJUgF

  • Mashup Score: 1
    Cancers - 11 month(s) ago

    Cancers, an international, peer-reviewed Open Access journal.

    Source: www.mdpi.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AmanChauhanMD
      AmanChauhanMD

      Please consider contributing to NETs Special Issue. Co-Guest editing with awesome @JaydiDelRivero https://t.co/wUGOZ3sVlI #mdpicancers via @Cancers_MDPI @SylvesterCancer @NCItreatment #NET #SCLC #LCNEC #MiNEN #NEC 🦓 https://t.co/qDM6Yk2Fgz

  • Mashup Score: 0
    Toronto, ON, CA - 1 year(s) ago

    The North American Neuroendocrine Tumor Society (NANETS) offers comprehensive, accredited medical education programs on NET disease that are developed by leading NET experts and designed exclusively for medical professionals. We also provide research grants, travel grants and education grants to young investigators doing preeminent work in the field of NET research. Visit our website to learn how…

    Source: nanets.net
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of AmanChauhanMD
      AmanChauhanMD

      Excited for my 🇨🇦 trip for Toronto @NANETS1 I will be talking on two of my favorite subjects!! #G3-NEN & #PRRT Drs. @HalletJulie and Simron Singh has put together a fantastic day of #NET education. https://t.co/Ey7ZtqDRm8. https://t.co/kETLWhxyTo

  • Mashup Score: 4
    4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today - Cedars-Sinai - Continuing Education (CE) - 1 year(s) ago

    Cedars-Sinai, 4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today, 3/18/2023 7:30:00 AM – 3/18/2023 2:00:00 PM, The fourth annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been…

    Source: cedars.cloud-cme.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of jgong15
      jgong15

      @PamelaKunzMD novel agents targeting #SSTR, #MGMT deficiency & temodar response, trials to watch in #GEPNETs & #NEC and #PRRT in #GEPNETS @TumorBoardTues and new concept of #PRRT rechallenge #SBNET @CSCancerCenter 4th Annual GI Tumor conf https://t.co/7s8rEqg0r4 @OncoAlert https://t.co/ehdFXLLYwW

    • Profile photo of AGangiMD
      AGangiMD

      #NET expert @PamelaKunzMD presenting on the evolving landscape of NET management @CSCancerCenter @CSCancerCenter 4th Annual GI Tumor conf https://t.co/sobXsAiK0Z @OncoAlert @DrHendifar @LACNETS @NANETS1 @YaleCancer https://t.co/zzIFqftiRa

Load More